{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:19:49Z","timestamp":1783639189393,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cumhuriyet University Scientific Research Society","award":["T-584"],"award-info":[{"award-number":["T-584"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04934-y","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:12:36Z","timestamp":1779127956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short-term synbiotic supplementation and intrahepatic triglyceride content assessed by proton MR spectroscopy: a pilot study"],"prefix":"10.1186","volume":"26","author":[{"given":"Omer","family":"Genc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Klisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena Kotur","family":"Stevuljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilge","family":"Oztoprak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Genc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Mercantepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Alagozlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"4934_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26062394","volume":"26","author":"I Berdowska","year":"2025","unstructured":"Berdowska I, Matusiewicz M, Fecka IA. Comprehensive review of metabolic dysfunction-associated steatotic liver disease: its mechanistic development focusing on methylglyoxal and counterbalancing treatment strategies. Int J Mol Sci. 2025;26:1\u201351.","journal-title":"Int J Mol Sci"},{"key":"4934_CR2","doi-asserted-by":"publisher","unstructured":"Ciftel E, et al. Assessing the impact of wheat flour and baker \u2019 s yeast restricted diet vs. calorie restriction in NAFLD patients. Arch Med Sci. 2024;1\u201310. https:\/\/doi.org\/10.5114\/aoms\/193393.","DOI":"10.5114\/aoms\/193393"},{"key":"4934_CR3","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/metabo14030153","volume":"14","author":"S Rafaqat","year":"2024","unstructured":"Rafaqat S, Gluscevic S, Mercantepe F, Rafaqat S, Klisic A. Interleukins: pathogenesis in non-alcoholic fatty liver disease. Metabolites. 2024;14:2024.","journal-title":"Metabolites"},{"key":"4934_CR4","first-page":"314","volume":"24","author":"P Shahapure","year":"2020","unstructured":"Shahapure P, Sharma S. Cardiovascular morbidity in diabetic non-alcoholic fatty liver disease (Nafld) using nafld fibrosis score as an early indicator. Turkish J Endocrinol Metab. 2020;24:314\u201320.","journal-title":"Turkish J Endocrinol Metab"},{"key":"4934_CR5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386.","journal-title":"Hepatology"},{"key":"4934_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5152\/tjg.2025.24760","volume":"36","author":"M Keskin","year":"2025","unstructured":"Keskin M, et al. Metabolic and hepatic profiles of non-obese and obese metabolic dysfunction-associated steatotic liver disease in adolescents: the role of fibroscan parameters,fibroblast growth factor-21, and cytokeratin-18. Turkish J Gastroenterol. 2025;36:152\u201361.","journal-title":"Turkish J Gastroenterol"},{"key":"4934_CR7","doi-asserted-by":"publisher","unstructured":"Termite F, Archilei S, D'Ambrosio F, Petrucci L, Viceconti N, Iaccarino R, et al. Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD. Antioxidants (Basel). 2025;14(1):56. https:\/\/doi.org\/10.3390\/antiox14010056. PMID: 39857390; PMCID: PMC11759774.","DOI":"10.3390\/antiox14010056"},{"key":"4934_CR8","doi-asserted-by":"publisher","unstructured":"Mignini I, Galasso L, Piccirilli G, Calvez V, Termite F, Esposto G, et al. Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD). Antioxidants (Basel). 2024;13(12):1532. https:\/\/doi.org\/10.3390\/antiox13121532. PMID: 39765860; PMCID: PMC11727446.","DOI":"10.3390\/antiox13121532"},{"key":"4934_CR9","doi-asserted-by":"publisher","unstructured":"Vallianou NG, Kounatidis D, Psallida S, Vythoulkas-Biotis N, Adamou A, Zachariadou T, et al. NAFLD\/MASLD and the Gut-Liver Axis: From Pathogenesis to Treatment Options. Metabolites. 2024;14(7):366. https:\/\/doi.org\/10.3390\/metabo14070366. PMID: 39057689; PMCID: PMC11278747.","DOI":"10.3390\/metabo14070366"},{"key":"4934_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","volume":"76","author":"Z Safari","year":"2019","unstructured":"Safari Z, G\u00e9rard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci. 2019;76:1541\u201358.","journal-title":"Cell Mol Life Sci"},{"key":"4934_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11112837","volume":"11","author":"C Xie","year":"2019","unstructured":"Xie C, Halegoua-Demarzio D. Role of probiotics in non-alcoholic fatty liver disease: does gut microbiota matter? Nutrients. 2019;11:1\u201322.","journal-title":"Nutrients"},{"key":"4934_CR12","doi-asserted-by":"publisher","unstructured":"Kanchanasurakit S, Kositamongkol C, Lanoi K, Nunta M, Saetuan T, Chaiyakunapruk N, et al. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. Front Nutr. 2022;9:880014. https:\/\/doi.org\/10.3389\/fnut.2022.880014. PMID: 35669067; PMCID: PMC9167056.","DOI":"10.3389\/fnut.2022.880014"},{"key":"4934_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5152\/erp.2025.24587","volume":"29","author":"L Payahoo","year":"2025","unstructured":"Payahoo L, Ghalichi F, Fathi M, Ehsani AA. Systematic review of the effect of probiotics, prebiotics, and synbiotics on gut microbiota in type 2 diabetes mellitus. Endocrinol Res Pract. 2025;29:267\u201376.","journal-title":"Endocrinol Res Pract"},{"key":"4934_CR14","doi-asserted-by":"publisher","unstructured":"Markowiak P, \u015ali\u017cewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9):1021. https:\/\/doi.org\/10.3390\/nu9091021. PMID: 28914794; PMCID: PMC5622781.","DOI":"10.3390\/nu9091021"},{"key":"4934_CR15","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1080\/17474124.2022.2016391","volume":"15","author":"R Yang","year":"2021","unstructured":"Yang R, et al. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2021;15:1401\u20139.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"4934_CR16","doi-asserted-by":"publisher","first-page":"105454","DOI":"10.1016\/j.fbio.2024.105454","volume":"62","author":"R Xiao","year":"2024","unstructured":"Xiao R, et al. The role of probiotics in the treatment of non-alcoholic fatty liver disease (NAFLD): New insights based on meta-analysis and subgroup analysis. Food Biosci. 2024;62:105454.","journal-title":"Food Biosci"},{"key":"4934_CR17","first-page":"1","volume":"12","author":"Y Tang","year":"2019","unstructured":"Tang Y, et al. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. Th Adv Gastroenterol. 2019;12:1\u201323.","journal-title":"Th Adv Gastroenterol"},{"key":"4934_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnut.2022.844242","volume":"9","author":"V Musazadeh","year":"2022","unstructured":"Musazadeh V, Roshanravan N, Dehghan P, Ahrabi SS. Effect of probiotics on liver enzymes in patients with non-alcoholic fatty liver disease: an umbrella of systematic review and meta-analysis. Front Nutr. 2022;9:1\u201310.","journal-title":"Front Nutr"},{"key":"4934_CR19","doi-asserted-by":"publisher","first-page":"107398","DOI":"10.1016\/j.phrs.2024.107398","volume":"208","author":"V Musazadeh","year":"2024","unstructured":"Musazadeh V, et al. The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2024;208:107398.","journal-title":"Pharmacol Res"},{"key":"4934_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.nutos.2024.05.014","volume":"56","author":"J Fadhilah","year":"2024","unstructured":"Fadhilah J, et al. Effect of synbiotic supplementation on liver function, metabolic profile and gut microbiota in non-alcoholic fatty liver disease (NAFLD): a meta-analysis of randomized controlled trials. Clin Nutr Open Sci. 2024;56:128\u201351.","journal-title":"Clin Nutr Open Sci"},{"key":"4934_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/ajpendo.00064.2004","volume":"288","author":"LS Szczepaniak","year":"2005","unstructured":"Szczepaniak LS, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol - Endocrinol Metab. 2005;288:1\u201333.","journal-title":"Am J Physiol - Endocrinol Metab"},{"key":"4934_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/jmri.21542","volume":"28","author":"GJ Cowin","year":"2008","unstructured":"Cowin GJ, et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging. 2008;28:937\u201345.","journal-title":"J Magn Reson Imaging"},{"key":"4934_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/foods10071580","volume":"10","author":"C Chaiyasut","year":"2021","unstructured":"Chaiyasut C, et al. Synbiotic supplementation improves obesity index and metabolic biomarkers in Thai obese adults : a randomized clinical trial. Foods. 2021;10:1\u201313.","journal-title":"Foods"},{"key":"4934_CR24","first-page":"1","volume":"17","author":"C Jim\u00e9nez-Gonz\u00e1lez","year":"2025","unstructured":"Jim\u00e9nez-Gonz\u00e1lez C, Alonso-Pe\u00f1a M, V\u00e9lez A, Crespo P, J., Iruzubieta P, Unraveling MASLD. The role of gut microbiota, dietary modulation, and ai-driven lifestyle interventions. Nutr. 2025;17:1\u201323.","journal-title":"Nutr"},{"key":"4934_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202\u20139.","journal-title":"J Hepatol"},{"key":"4934_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology (Baltimore MD). 2023. https:\/\/doi.org\/10.1097\/HEP.0000000000000520.","journal-title":"Hepatology (Baltimore MD)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04934-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:09:19Z","timestamp":1783638559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4934"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04934-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Cumhuriyet University (decision number 2013-12\/07, dated 10 December 2013) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}